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   Light-induced helical rearrangement of vertebrate visual rhodopsin was directly 
monitored by high-angle X-ray scattering (HAXS), ranging from Q (= 4πsinθ/λ) = 0.03 Å-1 
to Q = 1.5 Å-1. HAXS of nanodiscs containing single a rhodopsin molecule was performed 
before and after photoactivation of rhodopsin. The intensity difference curve obtained by 
HAXS agreed with that calculated from the crystal structure of dark state rhodopsin and 
metarhodopsin II, indicating that the conformational change of monomeric rhodopsin in the 
membrane is consistent with that occurring in the crystal. On the other hand, the HAXS 
intensity difference curve of nanodiscs containing two rhodopsin molecules was significantly 
reduced, similar to that calculated from the crystal structure of the deprotonated intermediate, 
without a large conformational change. These results suggest that rhodopsin is dimerized in 
the membrane, and that the interaction between rhodopsin molecules affects structural 
changes.  
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1. Introduction 
 
   Rhodopsin, which is located in the outer segment of rod visual cells in animal retinas, is a 
G-protein-coupled receptor (GPCR). Rhodopsin activates the G-protein transducin (Gt) in 
response to a photon. Structurally GPCRs share a common structural motif composed of 
seven transmembrane helices.1 Upon activation by stimuli, GPCRs undergo helical 
rearrangement, resulting in a conformational change, enabling them  to interact with their 
cognate G proteins on the cytoplasmic surface.2-10 
   Rhodopsin is composed of the apoprotein opsin and the light absorbing chromophore 11-
cis-retinal, which covalently binds to Lys residue of opsin via a Schiff base linkage. The 
Schiff base linkage is protonated to delocalize the π-electron system of the chromophore, 
which enables rhodopsin to absorb visible light. In dark state rhodopsin, the 11-cis-retinal 
chromophore acts as an inverse-agonist, which stabilizes the inactive conformation, 
substantially reducing G-protein activation efficiency.11 On photon absorption, the 11-cis-
retinal chromophore is isomerized to the all-trans form. After photoisomerization of the 
chromophore, a series of photobleaching intermediates such as bathorhodopsin, 
lumirhodopsin, metarhodopsin I, metarhodopsin II and metarhodopsin III is formed. In 
metarhodopsin II (Meta-II), a proton is released from the Schiff base linkage. As the 
protonated Schiff base is a core of the intramolecular hydrogen-bonding network, 
deprotonation of the Schiff base results in a substantial conformational change, resulting in 
the formation of the active state. 
   To date these helical rearrangements of GPCRs have been studied by various kinds of 
spectroscopy,12-16 as well as X-ray/electron crystallography.3-6, 9, 10 However, spectroscopy 
mainly provides highly localized information around the functional group. While 
crystallography shows the overall structure in detail, the protein structure in the crystal might 
be different from the native structure due to crystal packing. Recently, it was reported that 
solution X-ray scattering in the high-angle region (Q < 1.5 Å-1, where momentum transfer Q 
= 4πsinθ/λ) is a powerful tool to analyze helical rearrangements in seven transmembrane 
proteins, including rhodopsin17 and bacteriorhodopsin.18 
   Solution X-ray scattering experiments have been mainly applied to the small-angle 






IQI −= , where I(Q) is 
scattering intensity at Q, I(0) represents forward scattering, and Rg is the radius of gyration), 
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is valid. Using this approximation, Rg, which is the parameter showing the dimension of the 
scatterer, is obtained. Therefore, Guinier analysis is used to observe large-scale 
conformational changes, such as protein unfolding.19 On the other hand, information obtained 
from high-angle X-ray scattering (HAXS) corresponds to the distance between secondary 
structure elements. Therefore, fine conformational changes can be detected by HAXS, even if 
the conformational change is too small to cause any detectable change in Rg.  
   In this study, we directly monitored light-induced helical rearrangements of rhodopsin by 
HAXS. To address the long-standing issue of the dimerization of GPCRs, the effect of 
dimerization on conformational changes was assessed. The light-induced conformational 
change of the rhodopsin monomer, isolated in the nanodisc, was compared to that of the 
dimer in the nanodisc, or detergent-solubilized rhodopsin. The results demonstrated that the 
dimerization affects the extent of conformational changes, suggesting that an interaction 






2.1. Sample preparation 
   Bovine rod outer segments were prepared from bovine fresh retina. Retinas were removed 
from eye balls under dim red light. They were suspended in 40% sucrose (w/v) in ROS buffer 
(10 mM MOPS, 30 mM NaCl, 60 mM KCl, 2 mM MgCl2, 1 mM dithiothreitol, pH 7.5), 
vigorously shaken manually and centrifuged. The floating material and supernatant was twice 
diluted by ROS buffer, and centrifuged to collect ROS as the pellet. This manipulation was 
repeated 2 to 3 times.  
   Crude ROS was suspended in a small volume of ROS buffer, and layered on a 29%/35% 
(w/v in ROS buffer) sucrose stepwise gradient. After centrifugation, ROS in the interface 
between 29% and 35% sucrose was collected, and washed with ROS buffer several times. 
   The ROS membrane suspension was separated into three portions. Rhodopsin in one 
portion was solubilized by 1% dodecyl maltoside (DDM), and adsorbed on Concanavalin A 
Sepharose. After washing with DDM buffer (0.02% DDM, 50 mM HEPES, 140 mM NaCl, 
pH 6.0), rhodopsin was eluted by adding 300 mM α-methyl-D-mannopyranoside in DDM 
buffer, and concentrated to 30 mg/mL by ultrafiltration membrane (Centricon 30, Millipore).  
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   The other portions of ROS membrane suspension were used to prepare nanodisc (ND) 
samples.20, 21 Rhodopsin was solubilized with OG buffer (1% n-octyl-β-D-glucoside, 20 mM 
Tris/HCl, 100 mM NaCl, 0.5 mM EDTA, pH 7.4). Membrane scaffold protein (MSP) 
MSP1E3D1 was expressed in Escherichia coli, and purified by Ni-chelate affinity column 
chromatography.20 Rhodopsin, MSP1E3D1, and 1-palmitoyl-2-oleoyl-sn-glycero-3-
phosphocholine (POPC) were mixed at a molar ratio of 750:10:1 (lipids:MSP:pigment), to 
prepare ND containing a single rhodopsin molecule (Rh/ND), or 55:1:1 to prepare ND 
containing two rhodopsin molecules (2Rh/ND).22 ND was self-assembled by removing OG 
with dialysis against Buffer C (20 mM Tris/HCl, 100 mM NaCl, 0.5 mM EDTA, pH 7.4) at 
4 °C. The aggregates and liposomes were removed from the mixture using a Superdex 200 
column chromatography. The collected fractions contained empty ND, as well as Rh/ND or 
2Rh/ND. To remove empty ND, Concanavalin A Sepharose was added to the sample. After 
washing the resin several times, Rh/ND or 2Rh/ND was eluted by 300 mM α-methyl-D-
mannopyranoside in buffer D (50 mM HEPES, 140 mM NaCl, pH 6.0). After the buffer was 
exchanged to buffer D by PD-10 column, the sample was concentrated to 7 mg/mL rhodopsin 
(Rh/ND) or 17 mg/mL rhodopsin (2Rh/ND) by ultrafiltration membrane (Centricon 30, 
Millipore). The stoichiometry of rhodopsin (ε500nm = 40,600 M-1 cm-1) and MSP1E3D1 
(ε280nm = 29,910 M-1 cm-1) was estimated to be 1:2 for Rh/ND, and 1:0.9 for 2Rh/ND, by UV-
visible absorption spectra. Because one ND contains two MSP, ND in Rh/ND and 2Rh/ND 
preparations dominantly contains one or two rhodopsin molecules, respectively.  
   Empty ND for the control experiment was prepared by dialyzing the 1:75 mixture of MSP 
and POPC, followed by Superdex 200 column chromatography. 
 
2.2. Time-resolved UV-visible absorption spectroscopy 
   The photoreaction of rhodopsin was measured using a multichannel CCD spectrometer 
(C10000 system, Hamamatsu Photonics).23 Rhodopsin in the sample was photoactivated by a 
yellow flash generated by a short-arc xenon flash lamp (SA200, Nissin Electronic) and a 
glass optical filter (Y52, Asahi Techno Glass). The transient spectra were recorded every 100 
µs, and analyzed by singular value decomposition method21, 24 executed on Igor Pro 6.3. 
(WaveMetrix). 
 
2.3. High-angle X-ray scattering 
   High-angle X-ray scattering (HAXS) was measured at the beam line BL40B2 in SPring-8 
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(Hyogo, Japan). The sample (25 µL) was placed into a 2-mm-diameter quartz capillary 
(Hilgenberg 4017250), and illuminated from the top of the sample cell holder to 
photoactivate rhodopsin. For photoactivation of rhodopsin, yellow light (>500 nm) was 
generated by a 150-W cold light source (HL 150, Hoya-Schott), and passed through a glass 
optical filter (Y52, Asahi Techno Glass). The temperature of the sample was maintained at 
20 °C by circulating the temperature-controlled water in the capillary holder.  
   The concentric scattering image was obtained by R-AXIS VII (Rigaku), whose detector 
surface was 540 mm from the sample. The of X-ray wavelength was 1.0 Å, and the beam size 
was 0.4 (w) × 0.2 (h) mm. The sample was exposed to X-ray for 60 s to obtain one scattering 
image, and it took about 120 s for readout. The scattering curve (I vs Q) was calculated from 
the circular average of the scattering image. To reduce radiation damage, the sample stage 
was reciprocally moved (±0.5 mm, 0.5 Hz). Four scattering images were taken before 
photoactivation of rhodopsin. The sample was then irradiated for 30 s with yellow light, and 
four scattering images were taken. The amount of photoactivated rhodopsin was estimated by 
UV-visible absorption spectra, measured using a Shimadzu UV2400PC spectrophotometer. 
 
 
3. Results and Discussion 
 
3.1. Photoreaction of rhodopsin in DDM and nanodiscs  
   It has been reported that a metastable equilibrium mixture composed of Meta-I and Meta-
II is produced by the photoactivation of rhodopsin, and then Meta-III is slowly formed.25 It is 
well established that acidic pH and DDM biases this equilibrium to Meta-II.26, 27 In ND, the 
fraction of Meta-II, as well as the Gt activation efficiency of monomeric rhodopsin (Rh/ND), 
is greater than those of dimeric ones (2Rh/ND)28. Here, we compared the reactions of 
Rh/DDM, Rh/ND and 2Rh/ND at pH 6.0, in detail, by transient UV-visible absorption 
spectroscopy (Figure 1).  
   Rh/DDM, Rh/ND, and 2Rh/ND were excited by yellow flash, and transient difference 
spectra were recorded every 100 µs. Next the decay-associated difference spectra (DADS) 
were calculated by singular value decomposition analysis. DADS are exponential decay 
components, which essentially show the difference spectra between the photobleaching 
intermediates. The bleaching processes of Rh/DDM, Rh/ND, and 2Rh/ND, over a 10-4 to 103 
sec time scale, were represented by three processes (DADS1-DADS3) (Figure 1). In all 
samples, DADS1 and DADS2 showed a negative peak at 480 nm and positive peak at 380 
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nm, indicating that Meta-I heterologously decays to Meta-II. The time constants (τ=1/k) for 
DADS1 and DADS2 of Rh/DDM were about 1/10 those of Rh/ND, whereas those of 
2Rh/ND were 2 to 3 times greater than those of Rh/ND (Table 1). DADS3 showed a negative 
peak at 380 nm and positive peak at 450 nm, indicating the slow formation of Meta-III. The 
time constants for formation of Meta-III were not largely different from each other (Table 1). 
Because we did not observe the decay of Meta-III, the extrapolated spectra at infinite time 
(DADS0) show the difference spectra between dark state and the equilibrium mixture 
composed of Meta-I, Meta-II, and Meta-III. 
   Environmental effects on the equilibrium between Meta-I and Meta-II were assessed by 
analyzing the transient spectrum. Meta-I decays to Meta-II in the double-exponential reaction 
to form the equilibration mixture (DADS1 and DADS2), and then Meta-III is exponentially 
formed from the Meta-I/Meta-II mixture (DADS3). Therefore, the spectrum of Meta-I/Meta-
II equilibrium is obtained by subtracting DADS3 from DADS0. 
   Obtained spectra (Figure 2, red) were decomposed into the model difference spectra of 
Meta-I minus rhodopsin (green), and Meta-II minus rhodopsin (blue) to estimate the ratio of 
Meta-I and Meta-II (Figure 2 and Table 1). The resulting spectra (black) were in good 
agreement with the experimental curves (red). As reported previously, DDM stabilizes Meta-
II, whereas Meta-I is stabilized in 2Rh/ND. The slow formation of Meta-II, as well as the 
shift of the equilibrium in 2Rh/ND in comparison with Rh/ND, suggests an interaction 
between the rhodopsin molecules tethered in the ND. 
 
3.2. X-ray scattering profile of rhodopsin in DDM and nanodiscs 
   To obtain HAXS curves, scattering images were taken by R-AXIS VII, with 1-min 
exposure, and the concentric images were circularly averaged. The overall scattering curves 
of Rh/DDM, Rh/ND, 2Rh/ND, and empty ND are shown in Figure 3. The intensity of HAXS 
region was significantly smaller than that of the small-angle region (Q < 0.1 Å-1). 
   ND is composed of membrane scaffold protein (MSP) and lipid bilayer. Since MSP is an 
α-helical protein, the scattering from MSP may overlap with that of the α-helix of rhodopsin. 
In the scattering curves of Rh/DDM, Rh/ND, and 2Rh/ND, a characteristic shoulder was 
observed at Q = 0.65 Å-1 but not in empty ND, suggesting that the shoulder at Q = 0.65 Å-1 
represents the interhelical interference of rhodopsin molecule.29 To confirm this, the 
scattering curve was predicted from the crystal structure of rhodopsin. The scattering curve of 
monomeric rhodopsin in the dark state was calculated using the coordinates of polypeptide 
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(Met1-Ala348) and 11-cis-retinal, in a-chain of 1U19 by CRYSOL30 (Figure 3). The 
scattering curve of antiparallel dimer was similarly calculated using a- and b-chains and 11-
cis-retinal of 1U19. The shoulder at Q = 0.65 Å-1 was also present in these calculated curves, 
indicating that the packing of helices can be analyzed by HAXS. The shoulder is more 
prominent in 2Rh/ND than in Rh/ND, possibly due to the high ratio of rhodopsin to MSP (2:2 
for Rh/ND and 1:2 for Rh/ND). As 2Rh/ND contains parallel and antiparallel dimers in the 
ratio of 1:1,31 the scattering curve of 2Rh/ND represents the sum of the both dimers. 
 
3.3. Radiation Damage 
   HAXS curves were measured before and after photoactivation of rhodopsin, but the 
difference was found to be very small (Figure 3). To improve the signal-to-noise ratio in the 
limited amount of sample, measurements were repeated four times, before and after 
photoactivation. The the intensity changes upon photoactivation were then calculated using 
the averaged curves. These measurements were independently carried out 3 times for Rh/ND 
and empty ND (Figures 4a and 4b). 
   For Rh/ND, the intensity difference curves in the Q region from 0.4 to 1.2 Å-1 were 
reproducible. However, those below 0.4 Å-1 were not reproducible for Rh/ND, and a 
significant scattering change was observed for empty ND. These findings indicate that the 
scattering changes caused by the degradation of protein, and/or the ND by X-ray radiation are 
not negligible. Calculation of the different intensity curves between one measurement before 
illumination, and one measurement after illumination improved reproducibility, but the 
scattering changes caused by the X-ray radiation damage were still observed. Thus, we 
attempted to separate the X-ray scattering changes derived from structural change from those 
due to radiation damage (Figure 4c). 
   The scattering intensities at given Q in four scattering curves before photoactivation were 
plotted against the number of measurements (n = 1, 2, 3, 4). They were fitted with a linear 
line, and the intensity just before the photoactivation (n = 4.5) was extrapolated. Similarly, 
the intensities at Q in four scattering curves after photoactivation were plotted against the 
number of measurements (n = 5, 6, 7, 8), fitted with a linear line, and the intensity just after 
the photoactivation (n = 4.5) was extrapolated. Using these extrapolated intensities, the 
scattering intensity changes (ΔI) at Q were calculated, and plotted against Q (Figures 4d and 
4e). 
   While the signal-to-noise worsened, the reproducibility was found to be substantially 
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improved for Rh/ND. In addition, the flat baseline obtained from the empty ND implies that 
radiation damage can be removed by means of such data processing. The HAXS curves 
shown below were obtained by these calculations. 
 
 
3.4. High-angle X-ray scattering 
   The intensity difference curves upon photoactivation of rhodopsin in Rh/DDM, Rh/ND 
and 2Rh/ND were obtained, as described in the previous section (Figure 5). Under these 
experimental conditions (pH 6.0, 20 °C), Meta-II was dominantly formed, but within the 
equilibrium mixture containing Meta-I and Meta-III.25 Time-resolved UV-visible absorption 
spectroscopy demonstrated that the percentages of Meta-I in Meta-I/Meta-II equilibrium were 
13% in Rh/DDM, 20% in Rh/ND, and 30% in 2Rh/ND (Table 1). In addition, τ3 of these 
samples (Table 1) indicated that 40-50% of photoactivated rhodopsin was converted to Meta-
III during the X-ray scattering measurements (10 min). However, because the intensity 
difference curves just after photoactivation were extrapolated (see Figure 4c), the generation 
of Meta-III during the X-ray scattering measurements was not taken into consideration. We 
assumed that the scattering change for the formation of Meta-I was significantly smaller than 
that of Meta-II, based on the low-resolution structure of Meta-I32 and recent time-resolved 
HAXS measurements17. It should be noted that Meta-II consists of multiple substates with 
different conformations (Meta-IIa and Meta-IIb), and it is likely that the Meta-IIb is 
dominantly formed under the present experimental conditions (pH 6, 20°C).14, 33 The intensity 
of HAXS was normalized by the amount of Meta-II formed by photoactivation, which was 
estimated from the percentages of photoactivated rhodopsin (70-87%), and the equilibrium 
constant between Meta-I and Meta-II (Table 1).  
   In the intensity difference curves of Rh/DDM, Rh/ND, and 2Rh/ND, great intensity 
changes were observed in the small-angle region (Q < 0.2 Å-1) (Figure 5). The intensity 
change in this region is likely to reflect the overall shape of ND or DDM micelle. In addition, 
it was pointed out that phospholipids affect the scattering profile in this region.17, 18 
Therefore, we examined scattering changes in Q > 0.2 Å-1 (D < ~30 Å), to focus on the 
helical rearrangements of rhodopsin.  
   The intensity difference curve of Rh/DDM showed a sharp peak at Q = 0.2 Å-1, and broad 
valley at 0.6 Å-1, the latter of which corresponds to the characteristic shoulder showing the 
packing of helices (Figure 3). The intensity difference curve of Rh/ND essentially agreed 
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with that of Rh/DDM, while the peak at 0.2 Å-1 was greater than that in Rh/DDM. The 
intensity difference curve of 2Rh/ND was similar to that of Rh/DDM, rather than that of 
Rh/ND. Because these scattering changes were not observed in empty ND, it was concluded 
that they are derived from the conformational change of rhodopsin. 
   To date, conformational changes of rhodopsin during the photobleaching process have 
been studied in detail by X-ray/electron crystallography. While the conformational changes 
upon the formation of bathorhodopsin, lumirhodopsin, and Meta-I are small,32, 34, 35 
significant helical rearrangement is found to occur in Meta-II.5-8 When rhodopsin is 
photoactivated in solution and then crystallized, fully activated structures are obtained.5-7 On 
the other hand, if deprotonated intermediate is produced by irradiation of the crystal in dark 
state, the helical rearrangements are limited due to crystal packing.8 This structure (2I37) 
represents the model structure of Meta-IIa, in which the chromophore Schiff base is 
deprotonated but the conformational change is small.16, 33 To examine whether the 
conformational change in the membrane agrees with that in the crystal, the scattering curves 
of the intermediates were calculated from the crystal structures using CRYSOL.30  
   The scattering change for formation of Meta-II was calculated, using Met1-Asn326 and 
chromophore retinal in a-chain of 1U19 and 3PXO. 2I37 is trimeric and the structures are not 
homogeneous. Therefore, the scattering curves of c-chains of 2I37 and 2I36 were calculated, 
as c-chains undergo the largest conformational change among the three protomers. Because 
several amino acid residues were missing in 2I37 and 2I36, scattering profiles were 
calculated using Met1-Gly121, Ser127-Val230, Ala235, and Thr242-Cys322.  
   It was deduced that the large intensity change occurs due to the structural difference 
between 3PXO and 1U19, where elongation of helix V and outward tilt of helix VI occur. 
This intensity difference curve agreed with the experimental curve of Rh/ND, while the 
correction for the lipid bilayer17, 18 was not carried out. On the other hand, scattering change 
calculated from 2I37 and 2I36 showed a significantly reduced peak at 0.2 A-1. This curve was 
similar to those of Rh/DDM and 2Rh/ND, suggesting that structural changes are suppressed 
in these samples. This is consistent with the previous finding that the Gt activation efficiency 
of Meta-II in 2Rh/ND and DDM (0.01%) is significantly lower than that of Rh/ND.28 It is 
suspected that rhodopsin forms a dimer in 2Rh/ND, and that this dimerization suppresses 
conformational change. Reduced intensity in Rh/DDM also suggests the dimerization of 
rhodopsin in 0.02% DDM.36 However, the interhelical interference between the two 
protomers may reduce the scattering intensity change. To investigate this, we constructed the 
dimer models, and the intensity difference curves representing helical movement in the dimer 
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were deduced by CRYSOL. 
   The typical dimer forms of rhodopsin (1U19 and 1N3M) and opsin (3CAP) reported so 
far are shown in Figure 6. While 1U19 is an antiparallel dimer in which one protomer is 
flipped, 3CAP (a- and b-chains) and 1N3M (a- and c-chains) are parallel dimers which are 
likely to be present in the native disk membrane. Because the scattering curve predicted from 
the structure of Meta-II (3PXO) was indistinguishable from that from opsin (3CAP), we used 
opsin structure for the active conformation. In 3CAP, the helices VIII of the two protomers 
face each other (face-to-face parallel dimer), but they face away from each other in 1N3M 
(back-to-back parallel dimer) (Figures 6a and 6b, respectively). Using these structures as the 
template, the antiparallel dimer of opsin, face-to-face parallel dimer of the dark state, and 
back-to-back parallel dimer of opsin were generated using PyMOL (The PyMOL Molecular 
Graphics System, Version 1.7.0 Schrödinger, LLC), as follows.  
   The a-chain of 1U19 (Met1-Asn326) was superimposed on the a-chain of 3CAP (Met1-
Asn326) using the "align" command of PyMOL. Similarly, b-chain of 1U19 was 
superimposed on the b-chain of 3CAP. Aligned a- and b-chains of 1U19 were used to predict 
the scattering curve of the face-to-face parallel dimer of dark state (Figure 6a). Similarly, a- 
and b-chains of 3CAP were superimposed on a- and c-chains of 1N3M (Met1-Asn326) to 
generate the back-to-back parallel dimer of opsin (Figure 6b), and a- and b-chains of 3CAP 
were superimposed on a- and b-chains of 1U19 (Met1-Asn326), to generate the antiparallel 
dimer of opsin (Figure 6c).  
   The intensity difference curves for these conformational changes in the dimer were 
calculated using Met1-Asn326, and compared with the intensity difference curve of the 
monomer (Figure 6, bottom). In all dimers, it was found that the characteristic peak at 0.2 Å-1 
was not reduced, and the valley at 0.6 Å-1 was enhanced unlike in the experimental curve, 
strongly suggesting that the reduced intensity difference in 2Rh/ND was not derived from the 
interhelical interference between two protomers. It is likely that the structural change is 
suppressed in the dimer. However, since there appears to be enough space for outward 
movement of the helix VI (Figure 6), conformational change should not be suppressed simply 
by steric hindrance between the protomers. 
   These experiments show that the kinetics of the photobleaching process, the equilibrium 
between Meta-I and Meta-II, and the conformational change of rhodopsin in 2Rh/ND are 
different from those of Rh/ND. Therefore, it is likely that there is an interaction between two 
rhodopsin molecules tethered in ND, which suppresses the helical rearrangement upon 
photoactivation. In our 2Rh/ND sample, however, the orientation of the rhodopsin molecule 
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was not controlled, and therefore both the parallel and anti-parallel dimer would have been 
present.31 Physiologically, Meta-II is likely to be contained in the parallel Meta-II/rhodopsin 
heterodimer. Therefore, the relationship between the architecture of the dimer and the 
conformational change should be further investigated to elucidate the physiological relevance 




   Part of this research is based on the Cooperative Research Project of Research Institute of 
Electronics, Shizuoka University. The synchrotron radiation experiments were performed at 
the BL40B2 in the SPring-8, with the approval of the Japan Synchrotron Radiation Research 
Institute (JASRI) (Proposal No. 2011A1245, 2012A1263, 2012B1307, 2013A1136, 
2014A1247, and 2014B1219). 
 
 
- 12 - 
REFERENCES 
 
1 K. Palczewski, T. Kumasaka, T. Hori, C. A. Behnke, H. Motoshima, B. A. Fox, I. Le 
Trong, D. C. Teller, T. Okada, R. E. Stenkamp, M. Yamamoto and M. Miyano, 
Crystal structure of rhodopsin: A G protein-coupled receptor, Science, 2000, 289, 739. 
2 X. Deupi and J. Standfuss, Structural insights into agonist-induced activation of G-
protein-coupled receptors, Curr. Opin. Struct. Biol., 2011, 21, 541. 
3 J. H. Park, P. Scheerer, K. P. Hofmann, H. W. Choe and O. P. Ernst, Crystal structure 
of the ligand-free G-protein-coupled receptor opsin, Nature, 2008, 454, 183. 
4 P. Scheerer, J. H. Park, P. W. Hildebrand, Y. J. Kim, N. Krauss, H. W. Choe, K. P. 
Hofmann and O. P. Ernst, Crystal structure of opsin in its G-protein-interacting 
conformation, Nature, 2008, 455, 497. 
5 H. W. Choe, Y. J. Kim, J. H. Park, T. Morizumi, E. F. Pai, N. Krauss, K. P. Hofmann, 
P. Scheerer and O. P. Ernst, Crystal structure of metarhodopsin II, Nature, 2011, 471, 
651. 
6 X. Deupi, P. Edwards, A. Singhal, B. Nickle, D. Oprian, G. Schertler and J. 
Standfuss, Stabilized G protein binding site in the structure of constitutively active 
metarhodopsin-II, Proc. Natl. Acad. Sci. U. S. A., 2012, 109, 119. 
7 J. Standfuss, P. C. Edwards, A. D'Antona, M. Fransen, G. Xie, D. D. Oprian and G. F. 
Schertler, The structural basis of agonist-induced activation in constitutively active 
rhodopsin, Nature, 2011, 471, 656. 
8 D. Salom, D. T. Lodowski, R. E. Stenkamp, I. Le Trong, M. Golczak, B. Jastrzebska, 
T. Harris, J. A. Ballesteros and K. Palczewski, Crystal structure of a photoactivated 
deprotonated intermediate of rhodopsin, Proc. Natl. Acad. Sci. U. S. A., 2006, 103, 
16123. 
9 S. G. Rasmussen, B. T. DeVree, Y. Zou, A. C. Kruse, K. Y. Chung, T. S. Kobilka, F. 
S. Thian, P. S. Chae, E. Pardon, D. Calinski, J. M. Mathiesen, S. T. Shah, J. A. Lyons, 
M. Caffrey, S. H. Gellman, J. Steyaert, G. Skiniotis, W. I. Weis, R. K. Sunahara and 
B. K. Kobilka, Crystal structure of the β2 adrenergic receptor-Gs protein complex, 
Nature, 2011, 477, 549. 
10 A. K. Shukla, A. Manglik, A. C. Kruse, K. Xiao, R. I. Reis, W. C. Tseng, D. P. Staus, 
D. Hilger, S. Uysal, L. Y. Huang, M. Paduch, P. Tripathi-Shukla, A. Koide, S. Koide, 
W. I. Weis, A. A. Kossiakoff, B. K. Kobilka and R. J. Lefkowitz, Structure of active 
β-arrestin-1 bound to a G-protein-coupled receptor phosphopeptide, Nature, 2013, 
497, 137. 
11 R. Maeda, M. Hiroshima, T. Yamashita, A. Wada, S. Nishimura, Y. Sako, Y. 
Shichida and Y. Imamoto, Single-molecule observation of the ligand-induced 
population shift of rhodopsin, a G-protein-coupled receptor, Biophys. J., 2014, 106, 
915. 
12 R. Vogel and F. Siebert, Conformations of the active and inactive states of opsin, J. 
Biol. Chem., 2001, 276, 38487. 
13 B. Knierim, K. P. Hofmann, O. P. Ernst and W. L. Hubbell, Sequence of late 
molecular events in the activation of rhodopsin, Proc. Natl. Acad. Sci. U. S. A., 2007, 
104, 20290. 
14 M. Mahalingam, K. Martinez-Mayorga, M. F. Brown and R. Vogel, Two protonation 
switches control rhodopsin activation in membranes, Proc. Natl. Acad. Sci. U. S. A., 
2008, 105, 17795. 
15 Y. Yamazaki, T. Nagata, A. Terakita, H. Kandori, Y. Shichida and Y. Imamoto, 
Mapping of the local environmental changes in proteins by cysteine scanning, 
- 13 - 
Biophysics, 2014, 10, 1. 
16 Y. Yamazaki, T. Nagata, A. Terakita, H. Kandori, Y. Shichida and Y. Imamoto, 
Intramolecular interactions that Induce helical rearrangement upon rhodopsin 
activation: Light-induced structural changes in metarhodopsin IIa probed by cysteine 
S-H stretching vibrations, J. Biol. Chem., 2014, 289, 13792. 
17 E. Malmerberg, M. B.-G. PH, G. Katona, X. Deupi, D. Arnlund, C. Wickstrand, L. C. 
Johansson, S. Westenhoff, E. Nazarenko, X. S. GF, A. Menzel, W. J. de Grip and R. 
Neutze, Conformational activation of visual rhodopsin in native disc membranes, 
Science signaling, 2015, 8, ra26. 
18 M. Andersson, E. Malmerberg, S. Westenhoff, G. Katona, M. Cammarata, A. B. 
Wohri, L. C. Johansson, F. Ewald, M. Eklund, M. Wulff, J. Davidsson and R. Neutze, 
Structural dynamics of light-driven proton pumps, Structure, 2009, 17, 1265. 
19 M. Kataoka and Y. Goto, X-ray solution scattering studies of protein folding, Fold. 
Des., 1996, 1, R107. 
20 T. H. Bayburt, Y. V. Grinkova and S. G. Sligar, Self-assembly of discoidal 
phospholipid bilayer nanoparticles with membrane scaffold proteins, Nano Lett., 
2002, 2, 853. 
21 K. Kojima, Y. Imamoto, R. Maeda, T. Yamashita and Y. Shichida, Rod visual 
pigment optimizes active state to achieve efficient G protein activation as compared 
with cone visual pigments, J. Biol. Chem., 2014, 289, 5061. 
22 H. Tsukamoto, A. Sinha, M. DeWitt and D. L. Farrens, Monomeric rhodopsin is the 
minimal functional unit required for arrestin binding, J. Mol. Biol., 2010, 399, 501. 
23 Y. Imamoto, I. Seki, T. Yamashita and Y. Shichida, Efficiencies of activation of 
transducin by cone and rod visual pigments, Biochemistry, 2013, 52, 3010−3018. 
24 Y. Imamoto and Y. Shichida, Thermal recovery of iodopsin from photobleaching 
intermediates, Photochem. Photobiol., 2008, 84, 941. 
25 F. J. Bartl and R. Vogel, Structural and functional properties of metarhodopsin III: 
recent spectroscopic studies on deactivation pathways of rhodopsin, Phys. Chem. 
Chem. Phys., 2007, 9, 1648. 
26 B. König, W. Welte and K. P. Hofmann, Photoactivation of rhodopsin and interaction 
with transducin in detergent micelles. Effect of 'doping' with steroid molecules, FEBS 
Lett., 1989, 257, 163. 
27 J. H. Parkes and P. A. Liebman, Temperature and pH dependence of the 
metarhodopsin I-metarhodopsin II kinetics and equilibria in bovine rod disk 
membrane suspensions, Biochemistry, 1984, 23, 5054. 
28 T. H. Bayburt, A. J. Leitz, G. Xie, D. D. Oprian and S. G. Sligar, Transducin 
activation by nanoscale lipid bilayers containing one and two rhodopsins, J. Biol. 
Chem., 2007, 282, 14875. 
29 T. Kawaguchi, T. Hamanaka and Y. Kito, X-ray diffraction pattern from internal 
structure of bovine rhodopsin, J. Biochem., 1996, 119, 396. 
30 D. I. Svergun, C. Baberato and M. H. J. Koch, CRYSOL-a program to evaluate X-ray 
solution scattering of biological macromolecules from atomic coordinates, J. Appl. 
Crystallogr., 1995, 28, 768. 
31 S. Banerjee, T. Huber and T. P. Sakmar, Rapid incorporation of functional rhodopsin 
into nanoscale apolipoprotein bound bilayer (NABB) particles, J. Mol. Biol., 2008, 
377, 1067. 
32 J. J. Ruprecht, T. Mielke, R. Vogel, C. Villa and G. F. X. Schertler, Electron 
crystallography reveals the structure of metarhodopsin I, EMBO J., 2004, 23, 3609. 
33 E. Zaitseva, M. F. Brown and R. Vogel, Sequential rearrangement of interhelical 
networks upon rhodopsin activation in membranes: the Meta IIa conformational 
- 14 - 
substate, J. Am. Chem. Soc., 2010, 132, 4815. 
34 H. Nakamichi and T. Okada, Crystallographic analysis of primary visual 
photochemistry, Angew. Chem. Int. Ed. Engl., 2006, 45, 4270. 
35 H. Nakamichi and T. Okada, Local peptide movement in the photoreaction 
intermediate of rhodopsin, Proc. Natl. Acad. Sci. U. S. A., 2006, 103, 12729. 
36 B. Jastrzebska, T. Maeda, L. Zhu, D. Fotiadis, S. Filipek, A. Engel, R. E. Stenkamp 
and K. Palczewski, Functional characterization of rhodopsin monomers and dimers in 
detergents, J. Biol. Chem., 2004, 279, 54663. 
 
- 15 - 
Table 1: Spectroscopic characterization of rhodopsin samples 
Sample 
Meta-II formation  Meta-III formation 
Meta-I:Meta-II τ1 (s) τ2 (s)  τ3 (s) 
Rh/DDM 0.0004 0.0061  1237 13:87 
Rh/ND 0.0060 0.0664  923 20:80 
2Rh/ND 0.0160 0.1676  945 30:70 
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Figure Legends 
 
Figure 1: Photobleaching process of rhodopsin, in DDM and ND. The transient difference 
spectra after photoactivation were recorded over a 10-4 to 103-sec time scale. Decay-
associated difference spectra (DADS) for Rh/DDM (a), Rh/ND (b), and 2Rh/ND (c) were 
obtained by SVD analysis. The time constants for DADS1 (red), DADS2 (green), and 
DADS3 (blue) are shown in Table 1. Extrapolated difference spectra for t=∞ (DADS0) are 
also presented (black). 
 
Figure 2: The composition of Meta-I and Meta-II in the equilibrium. The difference spectra 
between Meta-I/Meta-II equilibrium mixture and dark state were calculated by subtracting 
DADS3 from DADS0 (t=∞) in Figure 1 (red). They were decomposed into the model 
difference spectra between Meta-I and rhodopsin (green), and between Meta-II and rhodopsin 
(blue). The resulting spectra (sum of model spectra, black) were in good agreement with the 
experimental ones (red). The ratios of Meta-I and Meta-II are shown in Table 1. 
 
Figure 3: X-ray scattering profile in the high-angle region. The scattering curves of Rh/DDM, 
Rh/ND, and 2Rh/ND were measured before (red) and after (blue) the photoactivation of 
rhodopsin. The scattering curves are presented using a logarithmic scale, and offset for 
comparison. The scattering curves of the rhodopsin monomer (a-chain of 1U19) and dimer 
(a- and b-chains of 1U19) were calculated by CRYSOL (green). 
 
Figure 4: X-ray radiation damage on ND. (a, b) Intensity difference curves before and after 
photoactivation of Rh/ND (a) and empty ND (b) were calculated using the averaged curves of 
four HAXS, curves before and after photoactivation. Intensity difference curves for three 
typical datasets are presented. (c) To obtain the intensity difference (ΔI) just before and after 
photoactivation, the intensities at given Q before (n = 1, 2, 3, 4) and after photoactivation (n = 
5, 6, 7, 8) were plotted, and extrapolated to n = 4.5. The example for Q = 0.22 Å-1 is 
presented. Populations of rhodopsin, Meta-I, Meta-II, and Meta-III estimated by the UV-
visible spectroscopy are illustrated below. For more details, see text. (d, e) ΔI for Rh/ND (d) 
and empty ND (e), obtained as shown in (c), are plotted against Q. Intensity difference curves 
for three typical datasets are presented. 
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Figure 5: Light-induced X-ray scattering changes of rhodopsin. The intensity was normalized 
by the amount of Meta-II, assuming that the scattering changes due to the formation of Meta-
I and Meta-III were substantially smaller than those due to the formation of Meta-II. The 
intensity difference curves were calculated using the crystal structures of Meta-II (3PXO) and 
rhodopsin (1U19), or those of deprotonated intermediate (Meta-II') (2I37, c-chain) and 
rhodopsin (2I36, c-chain). 
 
Figure 6: Model of the conformational change in the rhodopsin dimer. (a) Dark state structure 
(1U19, red) was superimposed on the structure if the face-to-face parallel dimer of opsin 
(3CAP, yellow). (b) Opsin structure (3CAP, yellow) was superimposed on the structure of the 
back-to-back parallel dimer of rhodopsin (a- and c-chains of 1N3M, red). (c) Opsin structure 
(3CAP, yellow) was superimposed on the structure of the antiparallel dimer of rhodopsin 
(1U19, red). The intensity difference curves predicted for the photoactivation of the 
rhodopsin dimers (red), in comparison with that of the rhodopsin monomer (blue), are shown 
below. 
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Graphic Abstract 
 
Light-induced conformational change of monomeric and dimeric rhodopsin in the nanodisc 
membrane was directly monitored by high-angle solution X-ray scattering.   
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